Evidence map›Paper›PMID 31045990›Full record

ArticleShock (Augusta, Ga.)2020

Monophosphoryl Lipid a Attenuates Multiorgan Dysfunction During Post-Burn Pseudomonas Aeruginosa Pneumonia in Sheep.

Satoshi Fukuda, Koji Ihara, Julia K Bohannon, Antonio Hernandez, Naeem K Patil, Liming Luan, Cody Stothers, Ryan Stark, Donald S Prough, David N Herndon and 2 more

Open access · greenAbstract read
In one paragraph

Article in Shock (Augusta, Ga.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Frontiers in pharmacology · 2022
    Article
  6. Article
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Satoshi FukudaDepartment of Anesthesiology, The University of Texas Medical Branch, Galveston, Texas.
Koji IharaDepartment of Anesthesiology, The University of Texas Medical Branch, Galveston, Texas.
Julia K BohannonDepartment of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee.
Antonio HernandezDepartment of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee.
Naeem K PatilDepartment of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee.
Liming LuanDepartment of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee.
Cody StothersDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee.
Ryan StarkDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.
Donald S ProughDepartment of Anesthesiology, The University of Texas Medical Branch, Galveston, Texas.
David N HerndonShriners Hospitals for Children, Galveston, Texas.
Edward R SherwoodDepartment of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee.
Perenlei EnkhbaatarDepartment of Anesthesiology, The University of Texas Medical Branch, Galveston, Texas.
Vanderbilt University Medical Center · USThe University of Texas Medical Branch at Galveston · USShriners Hospitals for Children - Galveston · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007347 · NIGMS · VANDERBILT UNIVERSITY · PI WILLIAMS, CHRISTOPHER S. · 1985 to 2023
$26.3M
Medical Scientist Training ProgramT32GM152284 · NIGMS · VANDERBILT UNIVERSITY · PI Christopher S. Williams · 2024 to 2026
$4.8M
Training Innate Immunity: A new approach to the treatment of SepsisR01GM119197 · NIGMS · EAST TENNESSEE STATE UNIVERSITY · PI SHERWOOD, EDWARD R, WILLIAMS, DAVID L. · 2016 to 2024
$4.6M
TIPS: Training in Perioperative ScienceT32GM108554 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Eric J Delpire · 2014 to 2026
$3.7M
Enhancing Resistance to Infection after Burn Injury with TLR AgonistsR01GM121711 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BOHANNON, JULIA K. · 2017 to 2021
$1.6M
Augmentation of Innate Anti-Microbial Immunity by TLR4 AgonistsR01GM104306 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ENKHBAATAR, PERENLEI, SHERWOOD, EDWARD R · 2013 to 2016
$1.2M
Prevention of Endothelial Injury by Toll-like Receptor 4 ModulatorsK08GM117367 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI STARK, RYAN J · 2015 to 2018
$734k
Enhancement of Innate Anti-Microbial Immunity Using Novel Synthetic TLR4 AgonistsK08GM123345 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HERNANDEZ, ANTONIO · 2017 to 2020
$699k
NIGMS NIH HHS K08 GM117367NIGMS NIH HHS K08 GM123345NIGMS NIH HHS R01 GM104306NIGMS NIH HHS R01 GM119197NIGMS NIH HHS R01 GM121711NIGMS NIH HHS T32 GM007347NIGMS NIH HHS T32 GM108554NIGMS NIH HHS T32 GM152284
6 · The paper itself

Abstract

backgroundMonophosphoryl lipid A (MPLA) is a TLR4 agonist that has potent immunomodulatory properties and modulates innate immune function to improve host resistance to infection with common nosocomial pathogens in mice. The goal of this study was to assess the safety and efficacy of MPLA in a sheep model of burn injury and Pseudomonas aeruginosa pneumonia. The sheep provides a favorable model for preclinical testing as their response to TLR4 agonists closely mimics that of humans.

methodsTwelve chronically instrumented adult female Merino sheep received 20% total body surface area, third-degree cutaneous burn under anesthesia and analgesia. At 24 h after burn, sheep were randomly allocated to receive: MPLA (2.5 μg/kg i.v., n = 6), or vehicle (i.v., n = 6). At 24 h after MPLA or vehicle treatment, Pseudomonas aeruginosa pneumonia was induced. Sheep were mechanically ventilated, fluid resuscitated and cardiopulmonary variables were monitored for 24 h after induction of pneumonia. Cytokine production, vascular barrier function, and lung bacterial burden were also measured.

resultsMPLA infusion induced small and transient alterations in core body temperature, heart rate, pulmonary artery pressure, and pulmonary vascular resistance. Pulmonary mechanics were not altered. Vehicle-treated sheep developed severe acute lung injury during Pseudomonas aeruginosa pneumonia, which was attenuated by MPLA as indicated by improved PaO2/FiO2 ratio, oxygenation index, and shunt fraction. Sheep treated with MPLA also exhibited less vascular leak, lower blood lactate levels, and lower modified organ injury score. MPLA treatment attenuated systemic cytokine production and decreased lung bacterial burden.

conclusionsMPLA was well tolerated in burned sheep and attenuated development of acute lung injury, lactatemia, cytokinemia, vascular leak, and hemodynamic changes caused by Pseudomonas aeruginosa pneumonia.

Indexed as

Adjuvants, ImmunologicAnimalsBurnsDisease Models, AnimalFemaleLipid AMultiple Organ FailurePneumonia, BacterialPseudomonas aeruginosaPseudomonas InfectionsSheepAdjuvants, ImmunologicLipid Amonophosphoryl lipid A

Identifiers

PMID31045990
PMCPMC6937402
OpenAlexW2943001122

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.